Patents by Inventor Dharini Rawal

Dharini Rawal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250008349
    Abstract: A human insulin-like growth factor (IGF) binding protein stock solution and method of making the same include a non-recombinant human IGF binding protein-3 (nr-IGFBP-3) in an aqueous buffered medium. The concentration of the nr-IGFBP-3 in the stock solution ranges from about 16 micrograms per milliliter (?g/ml) to about 40 ?g/ml. A kit includes a set of calibrators for nr-IGFBP-3. The set of calibrators includes the nr-IGFBP-3 in different concentrations.
    Type: Application
    Filed: September 4, 2024
    Publication date: January 2, 2025
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Spencer Lin, Kwasi Osae-Kwapong, Omar Quraishi, Seema Sinha, Michele Smith, SunRay DiFrancesco, Ryan Spears, Dharini Rawal, Debra Hovanec-Burns, Robert Owens
  • Patent number: 12167255
    Abstract: A human insulin-like growth factor (IGF) binding protein stock solution and method of making the same include a non-recombinant human IGF binding protein-3 (nr-IGFBP-3) in an aqueous buffered medium. The concentration of the nr-IGFBP-3 in the stock solution ranges from about 16 micrograms per milliliter (?g/ml) to about 40 ?g/ml. A kit includes a set of calibrators for nr-IGFBP-3. The set of calibrators includes the nr-IGFBP-3 in different concentrations.
    Type: Grant
    Filed: November 16, 2020
    Date of Patent: December 10, 2024
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Spencer Lin, Kwasi Osae-Kwapong, Omar Quraishi, Seema Sinha, Michele Smith, SunRay DiFrancesco, Ryan Spears, Dharini Rawal, Debra Hovanec-Burns, Robert Owens
  • Publication number: 20210072266
    Abstract: A human insulin-like growth factor (IGF) binding protein stock solution and method of making the same include a non-recombinant human IGF binding protein-3 (nr-IGFBP-3) in an aqueous buffered medium. The concentration of the nr-IGFBP-3 in the stock solution ranges from about 16 micrograms per milliliter (?g/ml) to about 40 ?g/ml. A kit includes a set of calibrators for nr-IGFBP-3. The set of calibrators includes the nr-IGFBP-3 in different concentrations.
    Type: Application
    Filed: November 16, 2020
    Publication date: March 11, 2021
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Spencer Lin, Kwasi Osae-Kwapong, Omar Quraishi, Seema Sinha, Michele Smith, SunRay DiFrancesco, Ryan Spears, Dharini Rawal, Debra Hovanec-Burns, Robert Owens
  • Publication number: 20190018025
    Abstract: A human insulin-like growth factor (IGF) binding protein stock solution and method of making the same include a non-recombinant human IGF binding protein-3 (nr-IGFBP-3) in an aqueous buffered medium. The concentration of the nr-IGFBP-3 in the stock solution ranges from about 16 micrograms per milliliter (?g/ml) to about 40 ?g/ml. A kit includes a set of calibrators for nr-IGFBP-3. The set of calibrators includes the nr-IGFBP-3 in different concentrations that are within a range of from about 0.5 ?g/ml to about 16 ?g/ml, which is configured to span a suspected range of IGFBP-3 analyte levels in an immunoassay of patient samples.
    Type: Application
    Filed: December 28, 2016
    Publication date: January 17, 2019
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Spencer Lin, Kwasi Osae-Kwapong, Omar Quraishi, Seema Sinha, Michele Smith, SunRay DiFrancesco, Ryan Spears, Dharini Rawal, Debra Hovanec-Burns, Robert Owens